IRADIMED (IRMD) Income Statement: Revenue & Earnings

IRADIMED Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

IRADIMED CORPORATION income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Revenue & Gross Profit
Revenue	73.24	65.56	53.30	41.81	31.72	38.52	30.44
Cost of Revenue	16.89	15.40	12.02	9.76	8.14	8.82	7.21
Gross Profit	56.35	50.16	41.28	32.05	23.57	29.70	23.23
Operating Expenses
Research & Development	2.83	2.82	2.28	1.87	1.87	1.43	1.52
Selling, General & Administrative	31.55	27.30	23.38	20.36	19.76	19.62	15.71
Operating Expenses	34.39	30.12	25.65	22.23	21.63	21.05	17.22
Operating Income	21.96	20.04	15.63	9.82	1.94	8.65	6.00
Other Income/Expense
Interest Income	2.19	1.86	0.58	0.03	0.13	0.00	0.24
Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Income/Expense	2.31	-1.70	-0.03	-0.02	8.00	8.42	-0.04
Income
Income Before Tax	24.28	21.74	16.18	9.84	-0.62	9.04	6.20
Income Tax Expense	5.04	4.55	3.35	0.51	-1.99	-0.59	-0.11
Net Income	19.23	17.19	12.83	9.33	1.37	9.63	6.30
Net Income - Continuous Operations	19.23	17.19	12.83	9.33	0.00	0.00	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBITDA	22.78	20.80	16.30	11.22	3.28	10.29	7.11
EBIT	24.28	20.04	15.63	9.82	1.94	9.04	6.00
Depreciation & Amortization	0.82	0.77	0.67	1.41	1.34	0.50	0.00
Earnings Per Share
Basic EPS	2.00	1.00	1.00	1.00	-	1.00	1.00
Diluted EPS	2.00	1.00	1.00	1.00	-	1.00	1.00
Basic Shares Outstanding	12.67	12.60	12.56	12.35	12.12	11.28	10.76
Diluted Shares Outstanding	12.78	12.72	12.64	12.59	12.44	12.28	12.11